|
|||||||||
|
2007 Program ScheduleThursday, October 11, 20077:00pm: Registration Friday, October 12, 20078:00 AM - 10:00 AM Session 1: Lipid Oxidation, Inflammation, and Vascular Disease Moderator: Norbert Leitinger, University of Virginia 8:00-8:30 AM- Norbert Leitinger, University of Virginia “Oxidation, Inflammation, and Vascular Disease” 8:30-9:00 AM- Suzanne Barbour, Virginia Commonwealth University “Lp-PLA2/PAF-AH Regulation”
9:00-9:30 AM- Aimee Landar, University of Alabama-Birmingham “Protein Modification by Oxidized Lipids”
9:30-9:45 AM- Jody Ullery, Vanderbilt University Medical Center "Triglyceride Enrichment Alters Cholesterol Metabolism and ER Stress in Macrophage Foam Cells"
9:45-10:00 AM- Samar Hammad, Medical University of South Carolina “Intracellular trafficking of free oxidized LDL and oxidized LDL immune complexes in macrophages” 10:00 AM - 10:30 AM BREAK 10:30 AM - 12:30 AM Session 2: Cellular Lipid Metabolism Moderator: Nobuyo Maeda, University of North Carolina-Chapel Hill
10:30-11:00 AM- Mike Altenburg, University of North Carolina-Chapel Hill “Human ApoE Isoforms and VLDL Clearance”
11:00- 11:30 AM- Mark Brown, Wake Forest University School of Medicine “Role of CGI-58 in Hepatic Lipid Mobilization and Secretion”
11:30- 12:00 AM- Shadab A. Siddiqi, University of Tennessee Health Sciences Center-Memphis “VLDL-transporting-vesicle (VTV): A New Member of the ER-derived Vesicle Family”
12:00- 12:30 AM- Larry Swift, Vanderbilt University Medical Center “Microsomal Triglyceride Transfer Protein: Another Lipid Droplet Protein?”
AFTERNOON FREE 7:00 PM - 9:00 PM Session 3: Steps in Chylomicron Formation and Export from the ER Moderator: Charles Mansbach, University of Tennessee Health Sciences Center-Memphis 7:00- 7:30 PM- Dennis Black, University of Tennessee Health Sciences Center-Memphis “Role of apo A-IV in Neonatal Lipid Absorption”
7:30- 8:00 PM- Mahmood Hussain, SUNY- Downstate Medical Center "Regulation of MTP and intestinal lipoprotein assembly".
8:00- 8:30 PM- Charles Mansbach, University of Tennessee Health Sciences Center-Memphis “The Regulation of Budding of the Pre-chylomicron Transport Vesicle from Intestinal ER”
8:30- 9:00 PM- Rosalind Coleman, University of North Carolina-Chapel Hill “Why Do We Need 4 (+?) Enzymes to Initiate Triacylglycerol Synthesis?” Saturday, October 13, 20078:00 AM - 10:00 AM Session 4: Diabetes, Metabolic Syndrome and Adipocyte Biology Moderator: Alyssa Hasty, Vanderbilt University Medical Center 8:00- 8:30 AM- Lisa Tannock, University of Kentucky “Diabetes, Obesity, and Inflammation: a Clinical Perspective” 8:30- 9:00 AM- Ron F. Morrison, University of North Carolina -Greensboro “Ubiquitin E3 Ligases in Targeted Protein Degradation during Adipocyte Hyperplasia” 9:00- 9:30 AM- Marshall (Barney) Elam, University of Tennessee Health Sciences Center “Transcriptional and Posttranscriptional Regulation of SREBP-1c by Insulin” 9:30- 9:45 AM- Jerod Denton, Vanderbilt University Medical Center “Accumulation of Adipocyte Triglyceride Triggers ER stress in Macrophages” 9:45- 10:00 AM- Saraswathi Viswanathan, Vanderbilt University Medical Center “Accumulation of Intracellular Free Fatty Acids Induces a Pro-inflammatory Response and Apoptosis in Macrophages”
10:00 AM - 10:30 AM BREAK 10:30 AM - 12:30 AM Session 5: HDL Structure and Function Moderator: Ling Li, University of Alabama at Birmingham 10:30- 10:50 AM- Ling Li, University of Alabama at Birmingham “HDL Dynamics: Assembly and Structural Plasticity of ApoA-I-Phospholipid Complexes”
10:50- 11:15 AM- James Patterson, University of Alabama at Birmingham “Computational Simulations of Model ApoA-I:Lipid Complexes”
11:15- 11:40 AM- Yan Ru Su, Vanderbilt University Medical Center “The effects of ApoA-I and ApoA-I Milano Variant on Macrophage Cholesterol Efflux and Atherosclerosis”
11:40- 12:05 AM- John S. Parks, Wake Forest University Health Science “Pre-beta HDL Formation and Metabolism”
12:05- 12:30 AM- Hong Wang, Temple University “Hyperhomocysteinemia with HDL Metabolism” _______________________________ 6:00 PM - 7:00 PM Saturday Evening Keynote Address Dr. Ira Tabas, Columbia University "Macrophage Death in Advanced Atherosclerosis" ______________________________ Sunday, October 14, 20078:00 AM - 10:00 AM Session 6: what are future targets for treatment among the apoB containing lipoproteins? Moderator: Virgil Brown, Emory University 8:00- 8:30 AM- Peter W. F. Wilson, Emory University “Lipid Assessment is Adequate”
8:30- 9:00 AM- W. Virgil Brown, Emory University “Apolipoproteins hold Promise as Targets”
9:00- 9:30 AM- Jim Otvos, LipoScience, Inc. “LDL particle number may be the best treatment target”
9:30- 10:00 AM- Nhoc-Anh Le, Emory University “Post-challenge Changes in Risk Assessment” 10:00 AM - 10:30 AM BREAK 10:30 AM - 12:30 AM Session 7: Immunity, lipids, and vascular disease: closing the gap Moderator: Amy Major, Vanderbilt University Medical Center 10:30-11:00 AM- Nilamadhab Mishra, Wake Forest University Health Sciences “Histone Deacetylases at the Crossroads of Inflammation and Lipid Metabolism”
11:00- 11:30 AM- Cornelia Weyand, Emory University “Immune Activation in the Atherosclerotic Plaque”
11:30- 11:50 AM- Vicki King, University of Kentucky “Interferon-g and the Interferon-Inducible Chemokine, CXCL10 Have Discordant Effects of Atherosclerosis and Aneurysm Formation”
11:50- 12:10 AM- Janusz Kabarowski, University of Alabama-Birmingham “Modulation of Lipoprotein metabolism and Atherosclerosis by the G2A Receptor”
12:10- 12:30 AM- Todd Hulgan, Vanderbilt University Medical Center “Dyslipidemia, Oxidant Stress, and Cardiovascular Disease during HIV Therapy” |
||||||||
 |
page updated 9/24/2007 | ||||||||
